Primary Care Enhanced Services
Overview
Summary, notice description and lot information
The NHS Lincolnshire Integrated Care Board is in the process of awarding a contract for Primary Care Enhanced Services under the Provider Selection Regime regulations. The procurement involves services within the health industry in Sleaford, United Kingdom, categorised as general practitioner services. The contract, valued at £201,772, is set from 1st April 2025 to 31st March 2026.
The procurement is at the 'Award' stage, with a standstill period ending on 10 September 2025 for representations. The process utilises a direct award without prior publication, underlining the absence of competitive tenders and aligning with the Health Care Services Regulations 2023. This tender offers promising opportunities for businesses specialising in health services, particularly those adept at delivering enhanced primary care services such as phlebotomy, minor injuries, and specialised drug monitoring.
It is well-suited for existing providers with proven quality and value, capable of integrating and collaborating to ensure service sustainability and improve access to health care. Small to medium enterprises, like The Deepings Practice, can particularly benefit from engaging with this award as the Provider Selection Regime encourages innovation and social value, addressing health inequalities and facilitating choice.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS201,772. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- AQP NOUS Service in North Kesteven
- AQP MRI Services in North Kesteven
- Review of Pain management Service on behalf of NHS Lincolnshire ICB in North Kesteven
- Community Dermatology and IPT Dermatology Activity in North Kesteven
- Primary Care Social Prescribing Service in North Kesteven
- Mental Health Social Prescribing Service in North Kesteven